CSI Market
Sign In | Register

Atrium Therapeutics Inc (RNA) Annual Balance Sheets

Annual · GAAP · USD millions
Access RNA quarterly Balance Sheets →
The balance sheet data below highlights changes in Atrium Therapeutics Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent382.52
Marketable Securities, Current SH0.00
Cash & Short-term Investments382.00
Other Current Assets1,314.35
Prepaid Expense, Current AS101.60
Total Current Assets1,798.47
Equipment/Property/Plant Net23.33
Prepaid Expense and Other Assets, Total0.00
Other Assets, Noncurrent136.25
Collaboration Receivables Current1,314.35
Operating Lease Right Of Use Asset2.80
Total Assets1,958.05
Liabilities
Accounts Payable, Current AC12.40
Accrued Liabilities, Current AC157.47
Other Liabilities, Current25.58
Deferred Compensation Liability, Current LI0.00
Total Current Liabilities195.45
Total Long-term Debt0.00
Other liabilities, Noncurrent74.00
Accrued Compensation And Other Current Liabilities21.64
Contract With Customer Liability Noncurrent45.31
Contract With Customer Liability Noncurrent28.69
Total Liabilities269.45
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock3,263.72
Retained Earnings / Accumulated Deficit-1,577.70
Other Equity2.56
Common Stockholder's Equity1,688.60
Total Stockholder's Equity1,688.60
Liabilities & Stockholder's Equity1,958.05
4 historic quarters locked

Sign in to unlock the full Atrium Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Atrium Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: rna-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-349488

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License